Pulse Entdecken nav.journalClub Debatten Trends Forschende Zeitschriften

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Start Entdecken nav.journalClub Trends

⌘+K

The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria | Synapse

September 21, 2006Open Access

View Full Paper

Der Komplementinhibitor Eculizumab bei paroxysmaler nächtlicher Hämoglobinurie

PHPeter HillmenLeeds Teaching Hospitals NHS Trust

Neal S. YoungBoston University JSJörg SchubertCellular Research (United States)

Key Points

Key points are not available for this paper at this time.

Abstract

Eculizumab ist eine effektive Therapie für PNH.

KI fragen

Like

Bookmark

Share

View Full Paper

KI fragen

Like

Bookmark

Share

View Full Paper

Cite This Study

Hillmen et al. (Thu,) haben diese Frage untersucht.

synapsesocial.com/papers/69dac59eaae38ff6ad8369a2 https://doi.org/https://doi.org/10.1056/nejmoa061648